» Cross-over of vaccines of women


Cross-over of vaccines of women

Previously randomized in the protocol 04-C-N191 (NCI)/IC 200403 (INCIENSA) titled: “Double-blind, controlled, randomized, phase III study of efficacy of an HPV16/18 VLP vaccine in the prevention of advanced cervical intraepithelial neoplasia (CIN2, CIN3, adenocarcinoma in situ [AIS] and invasive cervical cancer) associated with HPV16 and HPV18 cervical infection in healthy Young adult women in Costa Rica” (in collaboration with the National Cancer).

Since the efficacy study of the Human Papilloma Virus vaccine demonstrated that the vaccine was effective and safe, this study was done to offer women who participated in the vaccine who did not receive the vaccine initially.